Differences in Type I Interferon Signaling Antagonism by Dengue Viruses in Human and Non-Human Primate Cell Lines

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Medina, Freddy A ^a   Torres Malavé, Giselle ^b   Chase, Amanda J ^c   Santiago, Gilberto A ^a   Medina, Juan F ^a   Santiago, Luis M ^a   Muñoz Jordán, Jorge L ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^c MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN;

ANIMAL CELL; ARTICLE; DENDRITIC CELL; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PHYLOGENETIC TREE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CELL LINE; DENDRITIC CELLS; DENGUE VIRUS; HUMANS; INTERFERON TYPE I; MACACA MULATTA; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; VIRUS REPLICATION;

EID: 84928791497     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003468     Document Type: Article

References (57)

1. Halstead SB, (2008) Dengue. Tropical medicine: science and practice. London: Imperial College Press. pp. 75–122.
2. World-Health-Organization (2009) Dengue: guidelines for diagnosis, treatment, prevention and control.
3. Shi PY, (2012) Molecular virology and control of flaviviruses. Norfolk, UK: Caister Academic Press. vii, 358 p. p.
4. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230: 244–251. 9143280
5. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, et al. (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73: 4738–4747. 10233934
6. Rico-Hesse R, Harrison LM, Nisalak A, Vaughn DW, Kalayanarooj S, et al. (1998) Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg 58: 96–101. 9452299
7. Cologna R, Armstrong PM, Rico-Hesse R, (2005) Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 79: 853–859. 15613313
8. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2–9. 10608744
9. Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, et al. (2010) Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis 4: e699. doi: 10.1371/journal.pntd.0000699 20532230
10. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, et al. (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745–748. doi: 10.1126/science.1185181 20448183
11. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335–345. 17942531
12. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, et al. (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5: e926. doi: 10.1371/journal.pntd.0000926 21245912
13. Novick D, Cohen B, Rubinstein M, (1994) The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77: 391–400. 8181059
14. Mowen K, David M, (1998) Role of the STAT1-SH2 domain and STAT2 in the activation and nuclear translocation of STAT1. J Biol Chem 273: 30073–30076. 9804758
15. Gonzalez-Navajas JM, Lee J, David M, Raz E, (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12: 125–135. doi: 10.1038/nri3133 22222875
16. Haque SJ, Williams BR, (1994) Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. J Biol Chem 269: 19523–19529. 8034722
17. Li X, Leung S, Qureshi S, Darnell JE, Jr.Stark GR, (1996) Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem 271: 5790–5794. 8621447
18. de Veer MJ, Holko M, Frevel M, Walker E, Der S, et al. (2001) Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69: 912–920. 11404376
19. Melamed D, Tiefenbrun N, Yarden A, Kimchi A, (1993) Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol Cell Biol 13: 5255–5265. 7689148
20. Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, et al. (2004) Alpha-interferon and its effects on signalling pathways within cells. Curr Protein Pept Sci 5: 475–485. 15581417
21. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, et al. (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237–249. 12766484
22. Kadowaki N, Antonenko S, Lau JY, Liu YJ, (2000) Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192: 219–226. 10899908
23. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, et al. (2000) Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74: 4957–4966. 10799569
24. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, et al. (2007) Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 1: e86. 18060089
25. Hibberd ML, Ling L, Tolfvenstam T, Mitchell W, Wong C, et al. (2006) A genomics approach to understanding host response during dengue infection. Novartis Found Symp 277: 206–214; discussion 214–207, 251–203. 17319164
26. Guo JT, Hayashi J, Seeger C, (2005) West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79: 1343–1350. 15650160
27. Lin RJ, Liao CL, Lin E, Lin YL, (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78: 9285–9294. 15308723
28. Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, et al. (2005) Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79: 1934–1942. 15650219
29. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, et al. (2005) Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79: 12828–12839. 16188985
30. Umareddy I, Tang KF, Vasudevan SG, Devi S, Hibberd ML, et al. (2008) Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol 89: 3052–3062. doi: 10.1099/vir.0.2008/001594-0 19008393
31. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, et al. (2006) Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80: 9424–9434. 16973548
32. Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL, (2009) A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27: 2746–2754. doi: 10.1016/j.vaccine.2009.03.007 19366580
33. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, et al. (2010) The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 84: 3503–3515. doi: 10.1128/JVI.01161-09 20106931
34. Sharp TM, Hunsperger E, Santiago GA, Muñoz-Jordán JL, Santiago LM, et al. (2013) Virus-Specific Differences in Rates of Disease during the 2010 Dengue Epidemic in Puerto Rico. PLoS Negl Trop Dis 7: e2159. doi: 10.1371/journal.pntd.0002159 23593526
35. Medina F, Medina JF, Colon C, Vergne E, Santiago GA, et al. (2012) Dengue virus: isolation, propagation, quantification, and storage. Curr Protoc Microbiol Chapter 15: Unit 15D 12.
36. Lambeth CR, White LJ, Johnston RE, de Silva AM, (2005) Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 43: 3267–3272. 16000446
37. Johnson BW, Russell BJ, Lanciotti RS, (2005) Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol 43: 4977–4983. 16207951
38. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A, (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100: 14333–14338. 14612562
39. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, et al. (2005) Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79: 8004–8013. 15956546
40. Morrison J, Laurent-Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, et al. (2013) Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 9: e1003265. doi: 10.1371/journal.ppat.1003265 23555265
41. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, et al. (2005) Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 175: 3946–3954. 16148142
42. Perry ST, Buck MD, Lada SM, Schindler C, Shresta S, (2011) STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog 7: e1001297. doi: 10.1371/journal.ppat.1001297 21379341
43. Eckels KH, Brandt WE, Harrison VR, McCown JM, Russell PK, (1976) Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun 14: 1221–1227. 977127
44. Liu CC, (2004) Mosquito and mammalian cells grown on microcarriers for four‐serotype dengue virus production: Variations in virus titer, plaque morphology, and replication rate. Biotechnology and bioengineering 85: 482. 14760688
45. Cologna R, Rico-Hesse R, (2003) American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 77: 3929–3938. 12634353
46. Saluzzo JF, Cornet M, Castagnet P, Rey C, Digoutte JP, (1986) Isolation of dengue 2 and dengue 4 viruses from patients in Senegal. Trans R Soc Trop Med Hyg 80: 5. 3726996
47. Cardosa J, Ooi MH, Tio PH, Perera D, Holmes EC, et al. (2009) Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever. PLoS Negl Trop Dis 3: e423. doi: 10.1371/journal.pntd.0000423 19399166
48. Rico-Hesse R, (1990) Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174: 479–493. 2129562
49. Diallo M, Ba Y, Sall AA, Diop OM, Ndione JA, et al. (2003) Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999–2000: entomologic findings and epidemiologic considerations. Emerg Infect Dis 9: 362–367. 12643833
50. Franco L, Palacios G, Martinez JA, Vazquez A, Savji N, et al. (2011) First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa. PLoS Negl Trop Dis 5: e1251. doi: 10.1371/journal.pntd.0001251 21829739
51. Hanley KA, Guerbois M, Kautz TF, Brown M, Whitehead SS, et al. (2014) Infection Dynamics of Sylvatic Dengue Virus in a Natural Primate Host, the African Green Monkey. Am J Trop Med Hyg.
52. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, et al. (2008) Global trends in emerging infectious diseases. Nature 451: 990–993. doi: 10.1038/nature06536 18288193
53. Geisbert TW, Jahrling PB, (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110–121. 15577929
54. Mandl JN, Akondy R, Lawson B, Kozyr N, Staprans SI, et al. (2011) Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host. J Immunol 186: 6406–6416. doi: 10.4049/jimmunol.1001191 21515797
55. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077–1087. doi: 10.1038/nm.1871 18806803
56. Barreiro LB, Marioni JC, Blekhman R, Stephens M, Gilad Y, (2010) Functional comparison of innate immune signaling pathways in primates. PLoS Genet 6: e1001249. doi: 10.1371/journal.pgen.1001249 21187902
57. Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, et al. (2008) Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Veterinary Immunology and Immunopathology 125: 18–30. doi: 10.1016/j.vetimm.2008.05.001 18571243